Hanna Luke Nathan, Munster Liesbeth Jozefien, Joshi Shivani, Wendelien van der Bilt Jarmila Dagmara, Buskens Christianne Johanna, Hart Ailsa, Tozer Phil
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
Department of Surgery, Flevoziekenhuis, Almere, Netherlands; Department of Surgery, Amsterdam UMC, VUmc, Amsterdam, Netherlands.
Lancet Gastroenterol Hepatol. 2025 Aug;10(8):757-768. doi: 10.1016/S2468-1253(25)00007-X. Epub 2025 Apr 29.
Perianal fistulae can present a diagnostic challenge when distinguishing perianal Crohn's disease from idiopathic perianal fistulae. This distinction is key, as perianal Crohn's disease requires inflammatory bowel disease (IBD) therapy, whereas idiopathic perianal fistulae are primarily managed surgically. When luminal inflammation is absent, but Crohn's disease is suspected, the term isolated perianal Crohn's disease is sometimes applied. However, no formal guidance exists for diagnosing or managing isolated perianal Crohn's disease. Furthermore, whereas fistula granuloma might provide specific evidence of Crohn's disease, they are rarely detected in perianal fistulae, so are unlikely to sensitively delineate aetiology. This project aimed to develop an opinion-based framework for isolated perianal Crohn's disease. A systematic review evaluated clinical features suggestive of isolated perianal Crohn's disease and evidence for IBD therapies in patients with perianal fistulae without luminal IBD. The findings of this systematic review informed a multidisciplinary consensus process with IBD specialists, resulting in the formulation of diagnostic criteria and management recommendations for isolated perianal Crohn's disease. We then tested this diagnostic approach in a prospective cohort of 50 patients treated as having idiopathic perianal fistulae at a proctology referral centre, identifying six (12%) individuals as meeting the diagnostic criteria. Our findings underscore the scarcity of evidence guiding isolated perianal Crohn's disease diagnosis and the need for a composite risk-based assessment. The proposed framework provides a tool for clinical practice and research but requires validation and refinement. Clear communication with patients is essential, given the diagnostic and therapeutic uncertainties. Future studies should refine these criteria, explore biological markers for isolated perianal Crohn's disease, and establish evidence-based methods to differentiate isolated perianal Crohn's disease within the perianal fistulae spectrum.
在区分肛周克罗恩病与特发性肛周瘘管时,肛周瘘管可能带来诊断挑战。这种区分很关键,因为肛周克罗恩病需要进行炎症性肠病(IBD)治疗,而特发性肛周瘘管主要通过手术治疗。当不存在肠腔炎症但怀疑为克罗恩病时,有时会使用“孤立性肛周克罗恩病”这一术语。然而,对于诊断或管理孤立性肛周克罗恩病,目前尚无正式指南。此外,虽然瘘管肉芽肿可能提供克罗恩病的特异性证据,但在肛周瘘管中很少检测到,因此不太可能敏感地确定病因。本项目旨在为孤立性肛周克罗恩病制定一个基于意见的框架。一项系统评价评估了提示孤立性肛周克罗恩病的临床特征以及无肠腔IBD的肛周瘘管患者接受IBD治疗的证据。该系统评价的结果为与IBD专家进行的多学科共识过程提供了参考,从而制定了孤立性肛周克罗恩病的诊断标准和管理建议。然后,我们在一家直肠病转诊中心对50例被视为患有特发性肛周瘘管的患者进行的前瞻性队列研究中测试了这种诊断方法,确定有6例(12%)患者符合诊断标准。我们的研究结果强调了指导孤立性肛周克罗恩病诊断的证据稀缺,以及需要进行基于综合风险的评估。所提出的框架为临床实践和研究提供了一种工具,但需要验证和完善。鉴于诊断和治疗的不确定性,与患者进行清晰的沟通至关重要。未来的研究应完善这些标准,探索孤立性肛周克罗恩病的生物标志物,并建立基于证据的方法以在肛周瘘管范围内区分孤立性肛周克罗恩病。